Tenders
Dermatological drug tenders in Czechia
Dermatological drug tenders in Czechia: 147 listed on GranTender since 2024. The median awarded contract value is about €580,000 (242 contracts with a stated value). Buyers with the most tenders: Fakultní nemocnice Olomouc (28), Fakultní nemocnice Ostrava (13) and Krajská zdravotní, a.s. (10); suppliers with the most contract awards: Amgen s.r.o. (28), ROCHE s.r.o. (18) and Takeda Pharmaceuticals Czech Republic s.r.o. (10). Sources: Registr smluv, ISVZ (NIPEZ) and TED. In 2025 the median contract value was €390,000; 58% of contracts drew a single bid (1.6 bids on average). Data as of 19 November 2026; updated daily.
- Tenders
- 147
- Open tenders
- 0
- Awards
- 378
- Awarded value awarded
- €524,188,637
- Awarded value contract
- €63,539,041
- Awarded value framework ceiling
- €105,758,144
- Median contract value awarded
- ≈ €580,000
- Median contract value contract
- ≈ €100,000
- Median contract value framework ceiling
- ≈ €73,000
- Average bids per contract
- 1.5
- Tenders in 2025
- 67 +76% on 2024
Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.
Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.
Open tenders
No records yet.
Latest tenders
| Tender | Buyer | Estimated value | Status | Published |
|---|---|---|---|---|
| Léčivé přípravky s obsahem alopurinolu | Fakultní nemocnice Hradec Králové | CZK 819,900 (≈ €33,746) | Closed | 23 September 2026 |
| Léčivé přípravky s obsahem alopurinolu | Fakultní nemocnice Hradec Králové | CZK 819,900 (≈ €33,746) | Closed | 23 September 2026 |
| Dodávky LP - společný nákup | Fakultní nemocnice Bulovka | CZK 2,509,611,143 (≈ €103,293,182) | Closed | 21 September 2026 |
| Léčivé přípravky s obsahem botulotoxinu | Fakultní nemocnice Hradec Králové | CZK 13,584,731 (≈ €559,134) | Closed | 10 August 2026 |
| Léčivé přípravky s obsahem botulotoxinu | Fakultní nemocnice Hradec Králové | CZK 13,578,030 (≈ €558,859) | Closed | 10 August 2026 |
| Výzva č. 291 - Nusinersen – Dynamický nákupní systém na dodávky léčivých přípravků | Fakultní nemocnice Motol a Homolka | — | Awarded | 7 August 2026 |
| Léčivé přípravky s obsahem romosozumabu | Fakultní nemocnice Hradec Králové | CZK 6,184,000 (≈ €254,527) | Awarded | 3 August 2026 |
| Léčivé přípravky s obsahem romosozumabu | Fakultní nemocnice Hradec Králové | CZK 6,184,000 (≈ €254,527) | Awarded | 3 August 2026 |
| Léčivé přípravky s obsahem romosozumabu | Fakultní nemocnice Hradec Králové | — | Awarded | 31 July 2026 |
| DYNAMICKÝ NÁKUPNÍ SYSTÉM PRO PRŮBĚŽNÉ A OPAKOVANÉ NÁKUPY LÉČIVÝCH PŘÍPRAVKŮ_Červenec_27/2026 - HEMIHYDRÁT UPADACITINIBU | Všeobecná fakultní nemocnice v Praze | — | Awarded | 29 July 2026 |
| DNS – Kyselina hyaluronová | Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha | CZK 1,541,792 (≈ €63,459) | Closed | 2 July 2026 |
| Výzva č. 278 Burosumab – Dynamický nákupní systém na dodávky léčivých přípravků | Fakultní nemocnice Motol a Homolka | — | Awarded | 4 June 2026 |
| Přístroj na míchání mastí IV | Fakultní nemocnice Olomouc | — | Cancelled | 1 June 2026 |
| DYNAMICKÝ NÁKUPNÍ SYSTÉM PRO PRŮBĚŽNÉ A OPAKOVANÉ NÁKUPY LÉČIVÝCH PŘÍPRAVKŮ_Duben_9/2026 – BIMEKIZUMAB opakovaná | Všeobecná fakultní nemocnice v Praze | — | Awarded | 27 April 2026 |
| Přístroj na míchání mastí III | Fakultní nemocnice Olomouc | — | Cancelled | 14 April 2026 |
| VN Brno - Lebrikizumab 2026 III | Vojenská nemocnice Brno | — | Awarded | 27 March 2026 |
| Léčivé přípravky s obsahem cisatrakuria | Fakultní nemocnice Hradec Králové | CZK 2,453,610 (≈ €100,988) | Awarded | 24 March 2026 |
| Léčivé přípravky s obsahem cisatrakuria | Fakultní nemocnice Hradec Králové | CZK 2,453,610 (≈ €100,988) | Awarded | 24 March 2026 |
| Léčivé přípravky s obsahem cisatrakuria | Fakultní nemocnice Hradec Králové | — | Awarded | 23 March 2026 |
| VN Brno - Lebrikizumab 2026 II | Vojenská nemocnice Brno | — | Cancelled | 17 March 2026 |
Top buyers
- Fakultní nemocnice Olomouc28
- Fakultní nemocnice Ostrava13
- Krajská zdravotní, a.s.10
- Vojenská nemocnice Brno6
- Fakultní Thomayerova nemocnice4
- Domov pro seniory Zahradní Město4
- Institut klinické a experimentální medicíny2
- Městská nemocnice Ostrava, příspěvková organizace2
- Fakultní nemocnice Bulovka1
- Fakultní nemocnice Brno1
Top winners
Competition and prices
In 2025, half of the contracts were worth between €97,000 and €1.6 million, with a median of €390,000 (90 contracts with a stated awarded value). Contracts drew 1.6 bids on average (median 1) and 58% drew a single bid — based on 144 contracts with a known number of bids. Compared with 2024, in 2025 the median value fell 9% and the share of single-bid contracts fell from 86% to 58%. The usual procedures: open procedure (72%), other procedures (24%), negotiation without a call for competition (1%) — of 136 tenders with a stated procedure.
The most contracts went to Amgen s.r.o. (28), ROCHE s.r.o. (18) and Takeda Pharmaceuticals Czech Republic s.r.o. (10) — together 15% of all contracts.
| Year | Contracts | Median value | Middle half of values | Bids on average | Single bid |
|---|---|---|---|---|---|
| 2024 | 57 | €430,000 | €37,000 – €1.2 million | 1.3 | 86% (35) |
| 2025 | 149 | €390,000 | €97,000 – €1.6 million | 1.6 | 58% (144) |
| 2026 (so far) | 160 | €870,000 | €340,000 – €2.1 million | 1.5 | 73% (156) |
| All years | 370 | €610,000 | €170,000 – €1.9 million | 1.5 | 68% (335) |
Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.
Where you have a chance
Since 1 November 2024, 66% of the 315 contracts with a known number of bids had a single bid; the median was 1 bid. The number of bids is known for 315 of the 322 contracts from procedures with competition.
Buyers who often get few offers
The buyers below usually received one or two offers per contract — an offer from you would stand out.
| Buyer | Contracts with known bids | Median bids | Single bid |
|---|---|---|---|
| Fakultní nemocnice Olomouc | 34 | 2 | 24% |
| Nemocnice Znojmo, příspěvková organizace | 29 | 1 | 62% |
| Fakultní nemocnice Ostrava | 10 | 1 | 60% |
| Fakultní Thomayerova nemocnice | 9 | 2 | 44% |
In the last 12 months, 0 companies won their first contract in our records here — 0% of the 60 contracts (our records start on 1 January 2024).
Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.
Main CPV divisions
CPV codes of this topic
A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.
Dermatological and musculoskeletal drugs in neighbouring countries
Today, 5 tenders in the same niche are open in neighbouring countries.
- Germany — 3 open today · how to bid in Germany
- Poland — 2 open today · how to bid in Poland
Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.
Expected soon1
| Expected | Buyer | What | Why we expect it | Confidence |
|---|---|---|---|---|
| Dec 2026 – May 2027 | Nemocnice Znojmo, příspěvková organizace | Dermatological and musculoskeletal drugs | The current contract with Boehringer Ingelheim, spol. s r.o. ends on 2 June 2027; no new tender has been published yet. | medium |
Forecast from public data, not an announcement. Methodology.
Market reports
Dermatological and musculoskeletal drugs by city
Dermatological and musculoskeletal drugs in other countries
Dermatological and musculoskeletal drugs across Europe
Topics in Health, medical equipment and medicines
Questions and answers
- Where can I find dermatological drug tenders in Czechia?
- GranTender lists them in one place, from Registr smluv, ISVZ (NIPEZ) and TED, with their buyers, winners and contract values. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
- Who wins the most dermatological drug tenders in Czechia?
- By number of contracts won: Amgen s.r.o. (28), ROCHE s.r.o. (18), Takeda Pharmaceuticals Czech Republic s.r.o. (10).
- Which buyers publish the most dermatological drug tenders in Czechia?
- By number of tenders: Fakultní nemocnice Olomouc (28), Fakultní nemocnice Ostrava (13), Krajská zdravotní, a.s. (10).
- Which CPV codes belong to “Dermatological and musculoskeletal drugs”?
- 33630000 Medicinal products for dermatology and the musculo-skeletal system; plus tenders without a usable CPV code whose title names the topic.
- How many bids do dermatological drug tenders in Czechia receive on average?
- In 2025, contracts drew 1.6 bids on average (median 1) and 58% drew a single bid — based on 144 contracts with a known number of bids.
- How much are contracts for dermatological drug tenders in Czechia worth?
- In 2025, half of the contracts were worth between €97,000 and €1.6 million, with a median of €390,000 (90 contracts with a stated awarded value). Compared with 2024, in 2025 the median value fell 9% and the share of single-bid contracts fell from 86% to 58%.
- Which procedures are used for dermatological drug tenders in Czechia?
- The usual procedures: open procedure (72%), other procedures (24%), negotiation without a call for competition (1%) — of 136 tenders with a stated procedure.
- Which buyers get few offers in dermatological drug tenders in Czechia?
- Since 1 November 2024, these buyers usually received one or two offers per contract: Fakultní nemocnice Olomouc (median 2 bids over 34 contracts), Nemocnice Znojmo, příspěvková organizace (median 1 bid over 29 contracts) and Fakultní nemocnice Ostrava (median 1 bid over 10 contracts). Since 1 November 2024, 66% of the 315 contracts with a known number of bids had a single bid; the median was 1 bid.
CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.